MarketBeat Instant News Alerts 2 hours agoFidelity National Financial (NYSE:FNF) Posts Earnings Results, Beats Estimates By $0.08 EPSMarketBeatFidelity National Financial (NYSE:FNF - Get Free Report) announced its quarterly earnings results on Wednesday. The financial services provider reported $1.39 earnings per share for the quarter, beating analysts' consensus estimates of $1.31 by $0.08. Fidelity National Financial had a net margin of 5.10% and a return on equity of 15.49%. The firm had revenue of $4.05 billion during the quarter, compared to analysts' expectations of $3.79 billion. During the same period in the previous year, the company earned $1.16 earnings per share. Fidelity National Financial's quarterly revenue was up 11.4% compared to the same quarter last year. NYSE:FNFRead Fidelity National Financial (NYSE:FNF) Posts Earnings Results, Beats Estimates By $0.08 EPS2 hours agoF&G Annuities & Life (NYSE:FG) Releases Quarterly Earnings Results, Misses Estimates By $0.13 EPSMarketBeatF&G Annuities & Life (NYSE:FG - Get Free Report) issued its earnings results on Wednesday. The company reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.78 by ($0.13). F&G Annuities & Life had a return on equity of 10.73% and a net margin of 8.89%.The firm had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.49 billion. NYSE:FGRead F&G Annuities & Life (NYSE:FG) Releases Quarterly Earnings Results, Misses Estimates By $0.13 EPS2 hours agoe.l.f. Beauty (NYSE:ELF) Posts Quarterly Earnings Results, Beats Expectations By $1.04 EPSMarketBeate.l.f. Beauty (NYSE:ELF - Get Free Report) released its earnings results on Wednesday. The company reported $1.75 EPS for the quarter, topping analysts' consensus estimates of $0.71 by $1.04. The company had revenue of $479.37 million for the quarter, compared to the consensus estimate of $433.97 million. e.l.f. Beauty had a return on equity of 11.02% and a net margin of 1.61%.e.l.f. Beauty's quarterly revenue was up 35.5% compared to the same quarter last year. During the same quarter last year, the business posted $0.89 EPS. NYSE:ELFRead e.l.f. Beauty (NYSE:ELF) Posts Quarterly Earnings Results, Beats Expectations By $1.04 EPS2 hours agoEmergent Biosolutions (NYSE:EBS) Announces Quarterly Earnings ResultsMarketBeatEmergent Biosolutions (NYSE:EBS - Get Free Report) issued its quarterly earnings results on Wednesday. The biopharmaceutical company reported $0.60 earnings per share for the quarter, beating analysts' consensus estimates of ($0.08) by $0.68. The company had revenue of $234.30 million during the quarter, compared to the consensus estimate of $177.50 million. Emergent Biosolutions had a negative net margin of 1.27% and a positive return on equity of 10.76%. NYSE:EBSRead Emergent Biosolutions (NYSE:EBS) Announces Quarterly Earnings Results2 hours agoDynatrace (NYSE:DT) Announces Earnings Results, Beats Estimates By $0.04 EPSMarketBeatDynatrace (NYSE:DT - Get Free Report) released its quarterly earnings data on Wednesday. The company reported $0.48 EPS for the quarter, beating the consensus estimate of $0.44 by $0.04. The business had revenue of $554.55 million for the quarter, compared to the consensus estimate of $549.46 million. Dynatrace had a net margin of 8.06% and a return on equity of 10.37%. The business's revenue for the quarter was up 16.3% on a year-over-year basis. During the same period in the prior year, the firm earned $0.42 EPS. NYSE:DTRead Dynatrace (NYSE:DT) Announces Earnings Results, Beats Estimates By $0.04 EPS2 hours agoDelek US (NYSE:DK) Releases Quarterly Earnings ResultsMarketBeatDelek US (NYSE:DK - Get Free Report) announced its earnings results on Wednesday. The oil and gas company reported $5.48 EPS for the quarter, topping the consensus estimate of $2.67 by $2.81. Delek US had a negative net margin of 0.48% and a positive return on equity of 22.90%. The company had revenue of $4.09 billion for the quarter, compared to analysts' expectations of $3.44 billion. During the same period last year, the firm earned ($0.56) earnings per share. The business's revenue for the quarter was up 47.9% on a year-over-year basis. NYSE:DKRead Delek US (NYSE:DK) Releases Quarterly Earnings Results Trending News1Tilray Brands (NASDAQ:TLRY) Rating Increased to Strong-Buy at TD Securities2BlackBerry Limited $BB Shares Purchased by Renaissance Technologies LLC3Archer Aviation (ACHR) Projected to Announce Quarterly Earnings on Monday4Rocket Lab (RKLB) to Post Quarterly Earnings on Monday5Northland Securities Predicts BigBear.ai Q1 Earnings6Plug Power (PLUG) Expected to Release Quarterly Earnings on Monday7Advanced Micro Devices Q2 Earnings Call Highlights8Nokia (NYSE:NOK) Shares Up 2.3% - Here's Why All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoInsider Selling: Virtuix (NASDAQ:VTIX) COO Sells $15,303.40 in StockMarketBeatNASDAQ:VTIXRead Insider Selling: Virtuix (NASDAQ:VTIX) COO Sells $15,303.40 in Stock2 hours agoArcutis Biotherapeutics (NASDAQ:ARQT) Insider Patrick Burnett Sells 955 Shares of StockMarketBeatNASDAQ:ARQTRead Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Patrick Burnett Sells 955 Shares of Stock2 hours agoArcutis Biotherapeutics (NASDAQ:ARQT) Insider Sells $32,127.60 in StockMarketBeatNASDAQ:ARQTRead Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Sells $32,127.60 in Stock2 hours agoVirtuix (NASDAQ:VTIX) COO David Robert Malcolm Allan Sells 35,769 SharesMarketBeatNASDAQ:VTIXRead Virtuix (NASDAQ:VTIX) COO David Robert Malcolm Allan Sells 35,769 Shares2 hours agoInsider Selling: Natera (NASDAQ:NTRA) Insider Sells 295 SharesMarketBeatNASDAQ:NTRARead Insider Selling: Natera (NASDAQ:NTRA) Insider Sells 295 Shares2 hours agoNatera (NASDAQ:NTRA) CFO Michael Burkes Brophy Sells 317 SharesMarketBeatNASDAQ:NTRARead Natera (NASDAQ:NTRA) CFO Michael Burkes Brophy Sells 317 Shares2 hours agoInsider Selling: Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Sells $114,275.00 in StockMarketBeatNASDAQ:ARQTRead Insider Selling: Arcutis Biotherapeutics (NASDAQ:ARQT) Insider Sells $114,275.00 in Stock2 hours agoVirtuix (NASDAQ:VTIX) COO Sells $120,362.13 in StockMarketBeatNASDAQ:VTIXRead Virtuix (NASDAQ:VTIX) COO Sells $120,362.13 in Stock2 hours agoNatera (NASDAQ:NTRA) CFO Michael Burkes Brophy Sells 478 SharesMarketBeatNASDAQ:NTRARead Natera (NASDAQ:NTRA) CFO Michael Burkes Brophy Sells 478 Shares2 hours agoInsider Selling: ODDITY Tech (NASDAQ:ODD) CFO Sells 11,473 SharesMarketBeatNASDAQ:ODDRead Insider Selling: ODDITY Tech (NASDAQ:ODD) CFO Sells 11,473 Shares2 hours agoInsider Selling: Spyre Therapeutics (NASDAQ:SYRE) CFO Sells $716,775.00 in StockMarketBeatNASDAQ:SYRERead Insider Selling: Spyre Therapeutics (NASDAQ:SYRE) CFO Sells $716,775.00 in Stock2 hours agoSteven Leonard Chapman Sells 3,076 Shares of Natera (NASDAQ:NTRA) StockMarketBeatNASDAQ:NTRARead Steven Leonard Chapman Sells 3,076 Shares of Natera (NASDAQ:NTRA) Stock2 hours agoNatera (NASDAQ:NTRA) Insider Solomon Moshkevich Sells 3,410 Shares of StockMarketBeatNASDAQ:NTRARead Natera (NASDAQ:NTRA) Insider Solomon Moshkevich Sells 3,410 Shares of Stock2 hours agoDarien Spencer Sells 30,000 Shares of Ouster (NASDAQ:OUST) StockMarketBeatNASDAQ:OUSTRead Darien Spencer Sells 30,000 Shares of Ouster (NASDAQ:OUST) Stock2 hours agoSpyre Therapeutics (NASDAQ:SYRE) CEO Sells $1,432,650.00 in StockMarketBeatNASDAQ:SYRERead Spyre Therapeutics (NASDAQ:SYRE) CEO Sells $1,432,650.00 in Stock2 hours agoOportun Financial Q2 Earnings Call HighlightsMarketBeatNASDAQ:OPRTRead Oportun Financial Q2 Earnings Call Highlights2 hours agoNyxoah Q2 Earnings Call HighlightsMarketBeatNASDAQ:NYXHRead Nyxoah Q2 Earnings Call Highlights2 hours agoNews Q4 Earnings Call HighlightsMarketBeatNASDAQ:NWSRead News Q4 Earnings Call Highlights2 hours agoEverspin Tech Q2 Earnings Call HighlightsMarketBeatNASDAQ:MRAMRead Everspin Tech Q2 Earnings Call Highlights2 hours agoMannKind Q2 Earnings Call HighlightsMarketBeatNASDAQ:MNKDRead MannKind Q2 Earnings Call Highlights2 hours agoMirum Pharmaceuticals Q2 Earnings Call HighlightsMarketBeatNASDAQ:MIRMRead Mirum Pharmaceuticals Q2 Earnings Call Highlights2 hours agoMagnite Q2 Earnings Call HighlightsMarketBeatNASDAQ:MGNIRead Magnite Q2 Earnings Call Highlights2 hours agoMercadoLibre Q2 Earnings Call HighlightsMarketBeatNASDAQ:MELIRead MercadoLibre Q2 Earnings Call Highlights2 hours agoLegalZoom.com Q2 Earnings Call HighlightsMarketBeatNASDAQ:LZRead LegalZoom.com Q2 Earnings Call Highlights Featured Articles and OffersSpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have ControlBy Jeffrey Neal Johnson | August 3, 2026Trump's New DollarFrom Porter & Company (Ad)3 Fixed-Income ETFs Show Why Yield Is Only Part of the Income StoryBy Nathan Reiff | August 2, 2026System Upgrade: First Internet Bancorp Options SurgeBy Jeffrey Neal Johnson | August 4, 2026Tilray Brands (NASDAQ:TLRY) Rating Increased to Strong-Buy at TD SecuritiesBy MarketBeat | August 1, 2026Ready to give options a try? Your first trade (Ticker included) -INSIDEFrom Base Camp Trading (Ad)Microsoft Just Flipped the AI Spending Narrative OvernightBy Chris Markoch | July 30, 2026AbbVie Quietly Solved Its Biggest Problem—Now What?By Thomas Hughes | August 2, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 517 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
